<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Computer Science</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/746AD253-C2D4-40F6-89B0-C7E1E7424D2B"><gtr:id>746AD253-C2D4-40F6-89B0-C7E1E7424D2B</gtr:id><gtr:name>IXICO Ltd</gtr:name><gtr:address><gtr:line1>15 Long Lane</gtr:line1><gtr:postCode>EC1A 9PN</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/486975D3-B847-46E6-B21E-13D19260EB9A"><gtr:id>486975D3-B847-46E6-B21E-13D19260EB9A</gtr:id><gtr:name>Carlo Besta National Neurological Inst</gtr:name><gtr:address><gtr:line1>Via Celoria 11</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B475F34D-A340-48D6-AEE4-BB6C9E7CD25A"><gtr:id>B475F34D-A340-48D6-AEE4-BB6C9E7CD25A</gtr:id><gtr:firstName>Sebastien</gtr:firstName><gtr:surname>Ourselin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DB06558B-6851-4ED7-BD81-685D84649679"><gtr:id>DB06558B-6851-4ED7-BD81-685D84649679</gtr:id><gtr:firstName>Jania</gtr:firstName><gtr:surname>Aghajanian</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/46015271-9BA9-4097-9043-5125FEB722C2"><gtr:id>46015271-9BA9-4097-9043-5125FEB722C2</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:surname>Alexander</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/73771842-1F5F-417D-B3E9-1C95161A8FA9"><gtr:id>73771842-1F5F-417D-B3E9-1C95161A8FA9</gtr:id><gtr:firstName>Nick</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Fox</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/AA8AFD7A-1956-462F-941F-96D2F16657AC"><gtr:id>AA8AFD7A-1956-462F-941F-96D2F16657AC</gtr:id><gtr:firstName>Jonathan Mark</gtr:firstName><gtr:surname>Schott</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FJ020990%2F1"><gtr:id>A2B6253B-B41E-4043-98DC-50AC729E921D</gtr:id><gtr:title>Computational models of neurodegenerative disease progression</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/J020990/1</gtr:grantReference><gtr:abstractText>The project develops new computer science technology for modelling the progression of a disease or developmental process. It pioneers the use of state-of-the-art generative modelling and learning techniques to address this problem. It demonstrates the new approach by addressing questions of intense current interest in neurology: what is the sequence of clinical and pathological decline in two important diseases, Alzheimer's disease (AD) and fronto-temporal dementia (FTD), and how does it vary over the population? The methodological development introduces new and general-purpose techniques in computer science and the experimental work adds fundamental new knowledge in neurology.

The progression is the sequence of events that occurs as the disease or process advances. All diseases have an associated set of symptoms and pathologies. For example, AD causes loss of memory, personality changes, brain shrinkage, and deposits of abnormal proteins. However, other neurological diseases share many of these same occurrences. An additional fundamental characteristic that distinguishes diseases is the order in which the symptoms and pathologies appear. Knowledge, or a model, of this disease progression supports early diagnosis, which can maximize the effect of a treatment. It also provides insight into disease mechanisms that can accelerate development of the treatments. Furthermore, an effective model helps construct robust staging systems, which enable clinicians to tailor treatment and care plans for individual patients: so called &amp;quot;personalized medicine&amp;quot;.

Modelling disease progression, however, is a major challenge. First, the sequence of events can vary substantially among patients; monitoring a few individuals closely does not capture the variation over the larger population. Second, such close monitoring is often impossible, because the necessary examinations are too expensive or invasive to perform regularly. Thus, models must come from more cross-sectional data obtained from many patients each making a few irregular visits to a clinic. Very large data sets of this kind are available and contain a wealth of information, but current techniques for mining that information remain crude and do not exploit the available data effectively.

The investigators on this project recently introduced a new computational approach to disease progression modelling: the event-based model. Unlike standard models, it learns the sequence of events directly from a large cross-sectional data set without requiring a-priori staging or ordering of the patients. Preliminary results using small data sets from genetically confirmed disease cohorts demonstrate the uniquely rich description of disease progression the new approach can provide. However, application to larger and less-controlled data sets, where the real interest lies, presents major new challenges.

This project develops the event-based model from proof-of-concept to practical research tool. It then demonstrates the tool focussing on applications in neurological disease, although long-term applicability is much wider. In particular, we construct detailed models of the progression of AD and FTD, their variability over the population, and the influence of factors such as genetic profile. Finally, the project initiates exploration of the wider family of computational models of disease progression and their potential to extract new and fundamental information. For example, we introduce new models that potentially reveal disease subtypes, provide disease-staging systems, and highlight potential causal relationships among events.

The new model-based approach has the potential to revolutionize the way we think about disease progression and thus to make a major impact in diagnosis, disease management, and treatment development for some of the most devastating and widespread medical problems facing us today. The project initiates a long-term effort towards these ends.</gtr:abstractText><gtr:potentialImpactText>Management and treatment of neurodegenerative diseases is one of the biggest challenges facing medicine today. For example, Alzheimer's disease is the most common form of dementia, and the US alone currently has 5 million sufferers. Their direct medical costs exceed $250 billion and that figure is predicted to rise to $1 trillion by 2050. No disease-modifying drugs are currently available for AD or any other neurodegenerative disease. However, research into possible treatments is intensive and viable options are in the pipeline. To bring such treatments to market requires large-scale clinical trials with appropriate patient cohorts. Lack of early and accurate diagnosis is a major obstacle to these trials. The current gold-standard diagnosis for Alzheimer's disease remains post-mortem histology. The practical alternative remains clinical diagnosis, which has accuracy only around 80%, because the symptoms are easily confused with other dementias and psychiatric disorders.

The earlier and more accurate diagnosis and finer grained patient staging our new models offer will have a major impact both in the development of treatments, by identifying appropriate patient cohorts more precisely, and in designing personalized treatment plans for patients earlier and better. Greater specificity in cohort identification reduces patient numbers required for clinical trials reducing costs. The models also provide new sensitivity to the effects of treatments aiding identification of the most effective treatments more quickly. Both mechanisms accelerate the translation of effective treatments to market.

From an economic point of view in the UK, a treatment that increases by just one year the portion of the average AD patient's life during which they live independently could save in the region of 1 trillion pounds over the next 20 years: a major saving for the UK tax payer. The revenue for pharmaceutical companies marketing such a treatment will also add significantly to the economy. From a societal point of view, benefits of prolonged independence are clear not just for the patients but equally for their families and carers, whose lives are almost as deeply affected. 

The general approach we introduce here has wider application to many other diseases where similar savings and revenue-generating opportunities exist.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-02-29</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2013-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>592910</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Doctoral Prize (UCL)</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>Alexandra Young two year post-doctoral fellowship</gtr:fundingRef><gtr:id>8159E808-BB1F-45D0-8FA2-8ECFC19AEAF4</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>BAND Fellowship</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Michael J Fox Foundation</gtr:fundingOrg><gtr:id>EC30ED95-B098-402D-AA0E-9F04A3046FDC</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Engineering and Physical Sciences Research Council EPSRC</gtr:department><gtr:description>Computational PLatform for Assessment of Cognition In Dementia (C-PLACID)</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:fundingRef>EP/M020533/1</gtr:fundingRef><gtr:id>7B87D837-E7A6-4B1E-B27B-8D77E5572168</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Horizon 2020</gtr:department><gtr:description>EuroPOND: data-driven models for progression of neurological diseases</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:fundingRef>666992</gtr:fundingRef><gtr:id>39C47F0B-2089-4D53-A4BD-B9DDC05FE04B</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>266000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CHDI Research Funding Scheme</gtr:description><gtr:end>2019-06-02</gtr:end><gtr:fundingOrg>CHDI Foundation</gtr:fundingOrg><gtr:id>054D6604-FC96-47EE-8E6C-387EEB8C5020</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have developed new mathematical and computational modelling technology for revealing the long-term progression patterns of neurological diseases. It also identifies distinct subtypes within heterogeneous populations. The new technology has led to new insight into Alzheimer's disease; it extends to a wide range of other diseases, which on-going work focusses on; and potentially offers a powerful new tool for differential diagnosis and prognosis.</gtr:description><gtr:exploitationPathways>Lots of possibilities for developing the basic tools further, which we continue to explore under this grant and follow-on funding associated with it. The ideas have applications beyond neurodegenerative disease to other areas of medicine, such as cancer and infectious diseases, as well as basic development.</gtr:exploitationPathways><gtr:id>1FD9A0BA-0C64-47BF-B6A9-CEC4D35685C4</gtr:id><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://cmic.cs.ucl.ac.uk/pond/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A02742A-31D9-49A5-B9F9-074128200767"><gtr:id>4A02742A-31D9-49A5-B9F9-074128200767</gtr:id><gtr:title>Attenuation correction synthesis for hybrid PET-MR scanners: application to brain studies.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on medical imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5dd177e55516cdb2a12fd9c9d273bd2"><gtr:id>e5dd177e55516cdb2a12fd9c9d273bd2</gtr:id><gtr:otherNames>Burgos N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0278-0062</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F3CD2ED2-4191-42A9-8DF1-AC1EA4AAB94D"><gtr:id>F3CD2ED2-4191-42A9-8DF1-AC1EA4AAB94D</gtr:id><gtr:title>Brain imaging in the assessment for epilepsy surgery</gtr:title><gtr:parentPublicationTitle>The Lancet Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/125084f8829e7c3c78c31ed9b23e816e"><gtr:id>125084f8829e7c3c78c31ed9b23e816e</gtr:id><gtr:otherNames>Duncan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/14BFE39E-9F93-42DE-91AA-E33BF6C79643"><gtr:id>14BFE39E-9F93-42DE-91AA-E33BF6C79643</gtr:id><gtr:title>Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/33f6d1286765f98e3d1c0e7c6e23f4c5"><gtr:id>33f6d1286765f98e3d1c0e7c6e23f4c5</gtr:id><gtr:otherNames>Cash DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/782625A1-58F9-412E-8EA3-BBDBAD673A4A"><gtr:id>782625A1-58F9-412E-8EA3-BBDBAD673A4A</gtr:id><gtr:title>Measuring brain atrophy with a generalized formulation of the boundary shift integral.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/221fd26c37b11d63b6a518ca83bede2b"><gtr:id>221fd26c37b11d63b6a518ca83bede2b</gtr:id><gtr:otherNames>Prados F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B16D8A28-DA19-41D8-84EC-1B48E6D63209"><gtr:id>B16D8A28-DA19-41D8-84EC-1B48E6D63209</gtr:id><gtr:title>Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3da0bcae2f22f77961f0764e9f1c488c"><gtr:id>3da0bcae2f22f77961f0764e9f1c488c</gtr:id><gtr:otherNames>Heslegrave A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D7FBCEF8-E2FB-48E3-A8F0-C8EE6FFE5A1B"><gtr:id>D7FBCEF8-E2FB-48E3-A8F0-C8EE6FFE5A1B</gtr:id><gtr:title>Consensus between pipelines in structural brain networks.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eef5a8848319f1892777d6b653e1f135"><gtr:id>eef5a8848319f1892777d6b653e1f135</gtr:id><gtr:otherNames>Parker CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4E10372F-1BCB-4661-B9D1-E97A7DA9E344"><gtr:id>4E10372F-1BCB-4661-B9D1-E97A7DA9E344</gtr:id><gtr:title>Susceptibility artefact correction using dynamic graph cuts: application to neurosurgery.</gtr:title><gtr:parentPublicationTitle>Medical image analysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25cc4cd487dbc5f62d6ee03a4052e285"><gtr:id>25cc4cd487dbc5f62d6ee03a4052e285</gtr:id><gtr:otherNames>Daga P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1361-8415</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/376975C2-4BE2-4E6E-B5B4-46225FE586FA"><gtr:id>376975C2-4BE2-4E6E-B5B4-46225FE586FA</gtr:id><gtr:title>Longitudinal measurement of the developing grey matter in preterm subjects using multi-modal MRI.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/77c14863806a6af8ee3d5825bc068e5b"><gtr:id>77c14863806a6af8ee3d5825bc068e5b</gtr:id><gtr:otherNames>Eaton-Rosen Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/37CDACEC-1DCA-4EED-93E2-3B09A8DE73D2"><gtr:id>37CDACEC-1DCA-4EED-93E2-3B09A8DE73D2</gtr:id><gtr:title>In vivo imaging of tau pathology using multi-parametric quantitative MRI.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/910416dfe1e1fa70a891474bbc9375d7"><gtr:id>910416dfe1e1fa70a891474bbc9375d7</gtr:id><gtr:otherNames>Wells JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F7CFFC6-8BA7-423A-9FC0-49C9B6B30ECE"><gtr:id>5F7CFFC6-8BA7-423A-9FC0-49C9B6B30ECE</gtr:id><gtr:title>Brain volume estimation from post-mortem newborn and fetal MRI.</gtr:title><gtr:parentPublicationTitle>NeuroImage. Clinical</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e15f4c6f89f9595940a30bf4125bd1d2"><gtr:id>e15f4c6f89f9595940a30bf4125bd1d2</gtr:id><gtr:otherNames>Orasanu E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-1582</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E26B85D-C4B7-46C5-A135-4CCF3125EFE3"><gtr:id>0E26B85D-C4B7-46C5-A135-4CCF3125EFE3</gtr:id><gtr:title>Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/58C31457-1CF3-405F-BD81-6557370E1903"><gtr:id>58C31457-1CF3-405F-BD81-6557370E1903</gtr:id><gtr:title>Probabilistic non-linear registration with spatially adaptive regularisation.</gtr:title><gtr:parentPublicationTitle>Medical image analysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5658ab0e5ebcb7e508febb5dec2cc4c7"><gtr:id>5658ab0e5ebcb7e508febb5dec2cc4c7</gtr:id><gtr:otherNames>Simpson IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1361-8415</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/80D0B844-2367-4E34-B4BE-9E35C25ECAF4"><gtr:id>80D0B844-2367-4E34-B4BE-9E35C25ECAF4</gtr:id><gtr:title>A data-driven model of biomarker changes in sporadic Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c3045bf37ed392d59c58ced5672c1895"><gtr:id>c3045bf37ed392d59c58ced5672c1895</gtr:id><gtr:otherNames>Young AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/167DAA79-C168-4891-8E4D-6653AF8E9D80"><gtr:id>167DAA79-C168-4891-8E4D-6653AF8E9D80</gtr:id><gtr:title>Simulated field maps for susceptibility artefact correction in interventional MRI.</gtr:title><gtr:parentPublicationTitle>International journal of computer assisted radiology and surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c016e06dab4e53dadb4143f2ea0e1316"><gtr:id>c016e06dab4e53dadb4143f2ea0e1316</gtr:id><gtr:otherNames>Kochan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1861-6410</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/85CE0CE6-5333-48E3-A0B4-006EBD2EA3F1"><gtr:id>85CE0CE6-5333-48E3-A0B4-006EBD2EA3F1</gtr:id><gtr:title>A multi-time-point modality-agnostic patch-based method for lesion filling in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/221fd26c37b11d63b6a518ca83bede2b"><gtr:id>221fd26c37b11d63b6a518ca83bede2b</gtr:id><gtr:otherNames>Prados F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/79E8616E-77DB-4653-856F-EE232C76419B"><gtr:id>79E8616E-77DB-4653-856F-EE232C76419B</gtr:id><gtr:title>Right ventricle segmentation from cardiac MRI: a collation study.</gtr:title><gtr:parentPublicationTitle>Medical image analysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/668db2a1921309d1ae936b25cf9c4b64"><gtr:id>668db2a1921309d1ae936b25cf9c4b64</gtr:id><gtr:otherNames>Petitjean C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1361-8415</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B4F4BB6D-03F8-4CAC-9D4F-41FF701F8731"><gtr:id>B4F4BB6D-03F8-4CAC-9D4F-41FF701F8731</gtr:id><gtr:title>Imaging the accumulation and suppression of tau pathology using multiparametric MRI.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/248324647375bbbdfbd7c9cc13697946"><gtr:id>248324647375bbbdfbd7c9cc13697946</gtr:id><gtr:otherNames>Holmes HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7BC5CF42-1364-4F58-BD1B-325BFC3B26C8"><gtr:id>7BC5CF42-1364-4F58-BD1B-325BFC3B26C8</gtr:id><gtr:title>Bayesian model selection for pathological neuroimaging data applied to white matter lesion segmentation.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on medical imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2419f9cb06ddc16002a007bb9a52a42a"><gtr:id>2419f9cb06ddc16002a007bb9a52a42a</gtr:id><gtr:otherNames>Sudre CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0278-0062</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AC51A814-4B8F-4A3F-A925-8B3BB3B4EBE9"><gtr:id>AC51A814-4B8F-4A3F-A925-8B3BB3B4EBE9</gtr:id><gtr:title>Detection and modelling of contacts in explicit finite-element simulation of soft tissue biomechanics.</gtr:title><gtr:parentPublicationTitle>International journal of computer assisted radiology and surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d74eaa3fdf9f370d906d95a1e794a465"><gtr:id>d74eaa3fdf9f370d906d95a1e794a465</gtr:id><gtr:otherNames>Johnsen SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1861-6410</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3B8C14F3-9CB1-4931-BF6B-71C81F49F219"><gtr:id>3B8C14F3-9CB1-4931-BF6B-71C81F49F219</gtr:id><gtr:title>Stability, structure and scale: improvements in multi-modal vessel extraction for SEEG trajectory planning.</gtr:title><gtr:parentPublicationTitle>International journal of computer assisted radiology and surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b6a69e8dd306dc9dcc460ea8aead6b8f"><gtr:id>b6a69e8dd306dc9dcc460ea8aead6b8f</gtr:id><gtr:otherNames>Zuluaga MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1861-6410</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD9532F7-9513-47DA-B973-49BD43847CCE"><gtr:id>DD9532F7-9513-47DA-B973-49BD43847CCE</gtr:id><gtr:title>Fully-Automated ?MRI Morphometric Phenotyping of the Tc1 Mouse Model of Down Syndrome.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8f7821d45e197968a2159d1c9be04b69"><gtr:id>8f7821d45e197968a2159d1c9be04b69</gtr:id><gtr:otherNames>Powell NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0EE942A5-269C-4967-A77B-3A720BABE088"><gtr:id>0EE942A5-269C-4967-A77B-3A720BABE088</gtr:id><gtr:title>MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17382cff1959c3923015bbeb53626832"><gtr:id>17382cff1959c3923015bbeb53626832</gtr:id><gtr:otherNames>Harper L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/81732694-4B01-4D6E-BB29-1E28CF09F5CF"><gtr:id>81732694-4B01-4D6E-BB29-1E28CF09F5CF</gtr:id><gtr:title>Increased CSF neurogranin concentration is specific to Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c269bc0d2223200e9b90598a70904a8d"><gtr:id>c269bc0d2223200e9b90598a70904a8d</gtr:id><gtr:otherNames>Wellington H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BFC558D4-1F69-4533-9FE7-EA77D3013B27"><gtr:id>BFC558D4-1F69-4533-9FE7-EA77D3013B27</gtr:id><gtr:title>Diffusion imaging changes in grey matter in Alzheimer's disease: a potential marker of early neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Alzheimer's research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6446838f83f81f804d5ac791f0f7d797"><gtr:id>6446838f83f81f804d5ac791f0f7d797</gtr:id><gtr:otherNames>Weston PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/108D69C9-258D-4FE9-A943-571CB769FBFF"><gtr:id>108D69C9-258D-4FE9-A943-571CB769FBFF</gtr:id><gtr:title>Differential hippocampal shapes in posterior cortical atrophy patients: A comparison with control and typical AD subjects.</gtr:title><gtr:parentPublicationTitle>Human brain mapping</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cb3fedcf0ef05641298de9b8e222d870"><gtr:id>cb3fedcf0ef05641298de9b8e222d870</gtr:id><gtr:otherNames>Manning EN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1065-9471</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/13A0E956-EB93-4B8E-9D7A-4903E8FD6D2A"><gtr:id>13A0E956-EB93-4B8E-9D7A-4903E8FD6D2A</gtr:id><gtr:title>Detailed volumetric analysis of the hypothalamus in behavioral variant frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/91e8dbd4552d3ca97e5829f2f97fc986"><gtr:id>91e8dbd4552d3ca97e5829f2f97fc986</gtr:id><gtr:otherNames>Bocchetta M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B20B7DE-8DA0-472A-B2EF-CFAB123CF488"><gtr:id>8B20B7DE-8DA0-472A-B2EF-CFAB123CF488</gtr:id><gtr:title>Rapid processing of PET list-mode data for efficient uncertainty estimation and data analysis.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0aa6e15bd4346feb56ca40e1fd71bfab"><gtr:id>0aa6e15bd4346feb56ca40e1fd71bfab</gtr:id><gtr:otherNames>Markiewicz PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D1465F1C-42D9-4D8E-BE89-10EB0E36C2F6"><gtr:id>D1465F1C-42D9-4D8E-BE89-10EB0E36C2F6</gtr:id><gtr:title>aMAP is a validated pipeline for registration and segmentation of high-resolution mouse brain data.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8db51599a3890849aa83afad39ed9d2f"><gtr:id>8db51599a3890849aa83afad39ed9d2f</gtr:id><gtr:otherNames>Niedworok CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D3F8189A-0691-4AA1-9E7E-106334051460"><gtr:id>D3F8189A-0691-4AA1-9E7E-106334051460</gtr:id><gtr:title>Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia (Amsterdam, Netherlands)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6446838f83f81f804d5ac791f0f7d797"><gtr:id>6446838f83f81f804d5ac791f0f7d797</gtr:id><gtr:otherNames>Weston PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B1930A1E-35E3-4E63-B535-DD721AAE2656"><gtr:id>B1930A1E-35E3-4E63-B535-DD721AAE2656</gtr:id><gtr:title>Geodesic Information Flows: Spatially-Variant Graphs and Their Application to Segmentation and Fusion.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on medical imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf214a08f70dd705690d3294a5e05052"><gtr:id>bf214a08f70dd705690d3294a5e05052</gtr:id><gtr:otherNames>Cardoso MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0278-0062</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4DA5D7CE-2869-4AE6-BB8F-FE626D83FD47"><gtr:id>4DA5D7CE-2869-4AE6-BB8F-FE626D83FD47</gtr:id><gtr:title>Multi-contrast attenuation map synthesis for PET/MR scanners: assessment on FDG and Florbetapir PET tracers.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5dd177e55516cdb2a12fd9c9d273bd2"><gtr:id>e5dd177e55516cdb2a12fd9c9d273bd2</gtr:id><gtr:otherNames>Burgos N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ECA9B618-9176-4331-98BC-3443F276DCB2"><gtr:id>ECA9B618-9176-4331-98BC-3443F276DCB2</gtr:id><gtr:title>Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/28b7bc67e86a896d8699dccda7511ae9"><gtr:id>28b7bc67e86a896d8699dccda7511ae9</gtr:id><gtr:otherNames>Andrews KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9EE8401A-79C1-4FB6-B7EB-95F69E5F1A9F"><gtr:id>9EE8401A-79C1-4FB6-B7EB-95F69E5F1A9F</gtr:id><gtr:title>Effect of age at onset on cortical thickness and cognition in posterior cortical atrophy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c5c24de15719bab12a047926d3562be5"><gtr:id>c5c24de15719bab12a047926d3562be5</gtr:id><gtr:otherNames>Su?rez-Gonz?lez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3FEE9E72-56FE-4CB6-B66D-A32B2732D48B"><gtr:id>3FEE9E72-56FE-4CB6-B66D-A32B2732D48B</gtr:id><gtr:title>Longitudinal diffusion tensor imaging in frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/028989dcafa83dba91c03e918dc57a1d"><gtr:id>028989dcafa83dba91c03e918dc57a1d</gtr:id><gtr:otherNames>Mahoney CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A823DD2-F36E-484E-B03A-DA9BA7BBAB90"><gtr:id>4A823DD2-F36E-484E-B03A-DA9BA7BBAB90</gtr:id><gtr:title>Functional connectivity in autosomal dominant and late-onset Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b2295a11886f1b02ec603612b48e5b62"><gtr:id>b2295a11886f1b02ec603612b48e5b62</gtr:id><gtr:otherNames>Thomas JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92FF4011-EF58-4A39-A2E0-C3D9E0E04A88"><gtr:id>92FF4011-EF58-4A39-A2E0-C3D9E0E04A88</gtr:id><gtr:title>The NifTK software platform for image-guided interventions: platform overview and NiftyLink messaging.</gtr:title><gtr:parentPublicationTitle>International journal of computer assisted radiology and surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1a3e9b877e08fcfa7a2c57c11a169ae7"><gtr:id>1a3e9b877e08fcfa7a2c57c11a169ae7</gtr:id><gtr:otherNames>Clarkson MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1861-6410</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ADFA7797-941E-4681-B045-0A813F4CDBC0"><gtr:id>ADFA7797-941E-4681-B045-0A813F4CDBC0</gtr:id><gtr:title>Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy.</gtr:title><gtr:parentPublicationTitle>Clinical neurology and neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d624eb988e061ba80084b6a8f73eeea"><gtr:id>9d624eb988e061ba80084b6a8f73eeea</gtr:id><gtr:otherNames>Paterson RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0303-8467</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66128432-DFEE-4158-8645-3BD4D3F5D620"><gtr:id>66128432-DFEE-4158-8645-3BD4D3F5D620</gtr:id><gtr:title>APOE e4 is associated with disproportionate progressive hippocampal atrophy in AD.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cb3fedcf0ef05641298de9b8e222d870"><gtr:id>cb3fedcf0ef05641298de9b8e222d870</gtr:id><gtr:otherNames>Manning EN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E2F948D-1A75-415C-A01E-E9D51207CCFE"><gtr:id>0E2F948D-1A75-415C-A01E-E9D51207CCFE</gtr:id><gtr:title>Multimodal Image Analysis in Alzheimer's Disease via Statistical Modelling of Non-local Intensity Correlations.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d410b9903f6823797eb686df00539115"><gtr:id>d410b9903f6823797eb686df00539115</gtr:id><gtr:otherNames>Lorenzi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9E8F2B51-CCA7-4BC0-90B8-B0CADDFEE149"><gtr:id>9E8F2B51-CCA7-4BC0-90B8-B0CADDFEE149</gtr:id><gtr:title>Validation of clinical acceptability of an atlas-based segmentation algorithm for the delineation of organs at risk in head and neck cancer.</gtr:title><gtr:parentPublicationTitle>Medical physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8846230f3fab35577c0f8b71ef87df20"><gtr:id>8846230f3fab35577c0f8b71ef87df20</gtr:id><gtr:otherNames>Hoang Duc AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0094-2405</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C3C706B4-31F4-443B-BE07-C472451804F1"><gtr:id>C3C706B4-31F4-443B-BE07-C472451804F1</gtr:id><gtr:title>Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/358c8366abfb676293faedc26ce5bb5d"><gtr:id>358c8366abfb676293faedc26ce5bb5d</gtr:id><gtr:otherNames>Eshaghi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/J020990/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>EB5F16BB-2772-4DDE-BD6C-3B7A6914B64C</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>Info. &amp; commun. Technol.</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>96B4D986-4762-4E29-9962-0B2240D10CE2</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>Image &amp; Vision Computing</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>A759BB04-AFFE-4780-BD31-9A2707BC44BA</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Medical Imaging</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>